Effect of Antiplatelet Agents and Statins on Infrainguinal Bypass Graft Patency: Is There an Impact?  by Al-Nouri, Omar et al.
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Volume 54, Number 5 Abstracts 1545artery localization, and completion angiography were done with CO2 in all
patients, including hypogastric embolization in 26 cases. Preoperative na-
tional kidney foundation (NKF) glomerular filtration rate (GFR) classifica-
tion was: normal in 16 patients, mildly decreased in 52, moderate to severely
decreased in 44, and 2 were in renal failure.
Results: All grafts were successfully deployed with no conversions.
CO2 angiography identified 20 endoleaks (2 type 1, 16 type 2 and 2 type 4)
and 3 unintentionally covered arteries. Additional use of IC in 42 patients
did not modify the procedure in any case. When compared with a cohort of
50 consecutive patients who underwent EVAR done exclusively with IC, the
operative time was shorter with CO2 (177 vs 194min; P .01); fluoroscopy
time was less (21 vs 28min; P .002), and volume of iodinated contrast was
lower (37 vs 106 mLs; P .001). Postoperatively, there was one death, one
instance of renal failure, and no complications related to CO2 use. Patients
with moderate to severely decreased GFR undergoing EVAR with IC had a
12.7% greater (P  .004) decrease in GFR compared with the CO2 EVAR
group. At one, six and 12 month follow-up, CTAs showed well positioned
endografts with the expected patent renal and hypogastric arteries in all
patients, and no difference in endoleak detection compared with the iodin-
ated contrast EVAR group. During follow-up, 8 transluminal interventions
and one open conversion were required, but no aneurysm related deaths
occurred.
Conclusions: CO2 guided EVAR is technically feasible and safe, it
eliminates or reduces the need for iodinated contrast use, may expedite the
procedure, and avoids deterioration in renal function in patients with
pre-existing renal insufficiency. A prospective trial comparing CO2 with
iodinated contrast during EVAR is warranted.
Does a Regional Protocol for Ruptured Aortic Aneurysms Improve
Outcomes?
Alexander S. Tretinyak, MD, Christopher Solie, Adnan Z. Rizvi, MD, Peter
B. Alden, MD, Ross F. Garberich, John N. Graber, MD, Jason Q. Alexan-
der, MD, Timothy M. Sullivan, MD, Department of Vascular/Endovascu-
lar Surgery, Minneapolis Heart Institute at Abbott Northwestern Hospital,
Minneapolis, Minn
Objectives: Earlier diagnosis and shortened transfer times may im-
prove survival for ruptured aortic aneurysms (RAA). Endovascular aneurysm
repair (EVAR) requires specialized resources and planning prior to repair.
We analyzed the impact of a regional RAA specific protocol on time to
transfer, repair and survival at a large community based hospital.
Methods: A RAA protocol was developed to expedite evaluation,
transfer and treatment of RAAs, defined as retroperitoneal or free intra-
abdominal hemorrhage by CT scan. Educational visits were made and RAA
specific order sets were developed and distributed to referring and receiving
emergency departments (ED). A vascular surgeon evaluated each RAA in
our ED and assembled the appropriate team for EVAR or open repair. Data
collection began with the institution’s first EVAR for RAA,December 2006,
continuing prospectively to March 2011. Time from diagnosis to transfer,
arrival in our ED to treatment, and 30 day survival were primary endpoints.
Chi-squared or Fisher exact tests were used to compare categorical variables
and T-tests on log transformed values were used for continuous data.
Results: There were 13 control patients (62% EVAR) pre protocol and
31 patients (74% EVAR) following initiation of the protocol. There were 24
referring EDs; the furthest was 182 miles. Mean time from referring hospital
arrival to transfer decreased post protocol, (530 vs 261 min, P .44), as did
arrival at the referring hospital to treatment (601 vs 369 min, P  .32).
Thirty day survival improved from 69% to 85% (P  .161) post protocol.
Patients undergoing EVAR went from diagnosis to treatment more rapidly
post protocol (282 vs 215 min, P .49); open repair also improved (258 vs
101 min, P  .25). Fewer post protocol patients required post treatment
dialysis, 42% vs 7% (P  .006).
Conclusions: EVAR of RAA complements open surgery but requires a
compressed triage, decision, and planning period. A positive trend was
demonstrated using a defined regional protocol for RAA; times to diagnosis,
transfer, and treatment diminished, survival increased, and fewer patients
required dialysis. Given the small sample size, statistical significance was not
achieved.
The Hostile Landing Zone in Endograft Repair of the Thoracic Aorta:
The Next Frontier
Ali Shahriari, MD, James Williams, MD, Indiana Aortic Disease Institute,
Indianapolis, Ind
Objective: Thoracic endo-vascular repair of the aorta (TEVAR) is
gaining popularity in the treatment of thoracic aortic pathologies. One of the
limitations to the use of this treatment modality is unfavorable landing zone
(LZ) anatomy proximally and distally involving the aortic arch and visceral
branch vessels. We report our experience with extending the LZs using
endobranching and an on-table modified device design to offer a treatment
option to these high-risk patients.
A
(Methods: Between January 2009 and February 2011, 31 patients
nderwent TEVAR involving the supra-aortic or paravisceral branches.
ifteen patients (48%) were treated with adjunctive stenting of the supra-
ortic branches (“Snorkel” technique) and another 16 (52%) were treated
ith modified endovascular devices. Since January 2010 on-table modified
evices have been used in our institution to treat high-risk patients with
horacic and thoraco-abdominal aortic pathologies. Chart analysis was per-
ormed and data was collected. Endpoints were technical success, mortality,
aralysis, myocardial infarction, renal insufficiency, and branch vessel pa-
ency. The follow-up is 96.7%.
Results: There was 1 early and 2 late deaths (9.7%). The procedure
elated mortality was 0. The technical success for both techniques was 100%.
ne patient (3.2%) suffered acute on chronic renal insufficiency. One patient
3.2%) suffered an intraoperative stroke from a ruptured cerebral aneurysm.
ranch vessel patency for the patients treated with the snorkel technique was
3% and 100% for patients treated with the modified devices. There was one
ype I endoleak. The mean follow-up is 16 months.
Conclusion: Difficult LZ anatomy can be managed using both
he “snorkel” technique and modified devices. Currently these options
re offered to high-risk candidates. Detailed anatomical analysis and the
elationship of the branch vessels are imperative to the success of the
rocedure.
n Institutional Survey of the Use of Anti-Coagulation for Deep Vein
hromboses Below the Knee: What Is the Treatment Standard?
. Calloway Robertson, Ross Milner, MD, Vascular Surgery, Loyola Uni-
ersity Health System, Maywood, Ill
Objective: The ideal treatment for patients with deep vein thrombosis
DVT) below the knee remains undefined. Treatment recommendations
ange from conservative management to full-dose anti-coagulation. In our
tudy, we assessed practice patterns at a single institution for DVTs below
he knee.
Methods: Physicians were sent an email survey via Survey Monkey™
ith 8 multiple choice questions about management of DVT below
he knee. The questions addressed whether anti-coagulation was used;
he choices of anti-coagulation; use of follow-up duplex ultrasound; time
eriod before follow-up duplex ultrasound; the use of conservative
anagement; duration of anti-coagulation therapy; IVC filter use for
eep vein thrombosis below the knee; and the specialty of the physician.
he results were analyzed to compare current practices for treatment of
VT below the knee.
Results: A total of 99 physicians participated in the survey. Of these 99
articipants, 48 (48.5%) stated that they anti-coagulate patients with DVTs
elow the knee and 51 (51.5%) do not anti-coagulate. Of the 48 physicians
hat anti-coagulate, 62.3% use LMW heparin. IV heparin was used by 11%
nd anti-platelet agents were used by 7.5%. Of the 51 physicians who do not
nti-coagulate patients with DVT below the knee, 71.2% reassessed for clot
ropagation or resolution with a duplex exam. 48% obtain follow-up duplex
cans at 1 week, 37% at 2 weeks, and 11.1% at 1 month post-initial duplex
can. The length of anti-coagulation was 3 months for 58% of the 48
articipants who anti-coagulate patients and 30% anti-coagulate for 6
onths. IVC filters were used by 46% when there was a contraindication to
nti-coagulation and used by 13.7% when clot propagation was noted by
ollow-up duplex scan. 45.5% specialized in medicine, 11.1% surgery, 5.1%
eurosurgery, and 5.1% Ob/gyne.
Conclusions: These results suggest that there is no difference be-
ween the numbers of physicians anti-coagulating patients with DVT
elow the knee as compared to conservative management. There is
ubstantial variability in the medications used to anti-coagulate patients.
his institutional survey suggests that there is no standard practice for the
se of anti-coagulation for treatment of DVT below the knee. In addi-
ion, there is a higher than expected rate of IVC filters placed for DVT
elow the knee.
ffect of Antiplatelet Agents and Statins on Infrainguinal Bypass Graft
atency: Is There an Impact?
mar Al-Nouri, DO, Andrew Gassman, MD, Leah Phillippi, R. Hersh-
erger, P. Halandras, Ross Milner, MD, Bernadette Aulivola, MD, Loyola
niversity Medical Center, Maywood, Ill
Objective: We hypothesized medications that are commonly pre-
cribed for atherosclerosis influence infrainguinal bypass graft patency.
Methods: We retrospectively reviewed all infrainguinal bypasses per-
ormed at a single institution between January 2006 and December 2009.
e collected data on demographics, comorbidities, medications, graft char-
cteristics, graft patency, limb salvage, and mortality.
Results: We identified 112 patients who underwent 116 infrainguinal
ypasses during the study period. Mean age was 65 and 58% were men. Bypass
as performed for critical limb ischemia in 78% and claudication in 22%.
utologous vein was used in 37% and prosthetic grafts in 63%. Most grafts
65%) crossed the knee to distal targets. Coexisting diseases included hyperten-
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November 20111546 Abstractssion (78%), diabetes (47%), hyperlipidemia (50%), coronary artery disease
(25%), congestive heart failure (12%), chronic obstructive pulmonary disease
(8%), hemodialysis dependence (15%) and active tobacco use (27%). Use of
several medications increased after bypass: aspirin (51% to 66%), statins (53% to
62%), beta blockers (37% to 50%). Clopidogrel use was unchanged after bypass
(33%). Mean follow up was 342 days (range 3-1591 days). At two-years,
cumulative graft patency was 67%, limb salvage was 67%, and survival was 81%.
Aspirin usage increased secondary graft patency from 46% to 83% (P  .005)
and 51% to 73% (P  .05), respectively. Usage of clopidogrel or beta-blocker
did not have a statistically significant effect on patency. Statin usage increased
secondary graft patency from 59% to 73% (P .03).
Conclusion: Medications commonly prescribed for atherosclerosis such as
aspirin and statins demonstrated patency benefit in patients undergoing infraingui-
nal bypass in a population with predominantly critical limb ischemia.
Nonlinear Mechanical Behavior of the Common, External, and Inter-
nal Carotid Arteries In Vivo
Alexey V. Kamenskiy, PhD, Yuris A. Dzenis, PhD, Jason N. MacTaggart,
MD, Thomas G. Lynch, MD, Syed A Jaffar Kazmi, MD, Iraklis I. Pipinos,
MD, Engineering Mechanics, University of Nebraska-Lincoln, Lincoln,
Neb
Introduction: The mechanical environment and properties of the
carotid artery play an important role in the formation and progression of
atherosclerosis in the carotid bifurcation. The purpose of this work was to
measure and compare the range and variation of circumferential stress and
tangent elastic moduli in the human common (CCA), external (ECA) and
internal (ICA) carotid arteries over the cardiac cycle in vivo.
Methods:Measurements were performed in the surgically exposed prox-
imal cervical CCA, distal ECA and distal ICAof normotensive patients (n 16)
undergoing carotid endarterectomy. All measurements were completed over
the cardiac cycle in the repaired bifurcation. B-mode Duplex ultrasonography
and semi-automatic segmentation algorithm were used to track changes in the
arterial diameter and wall thickness in response to pressure measured concur-
rently with an angiocatheter placed in theCCA.Thesemeasurements were then
used to calculate the variation of circumferential stresses, tangent elasticmoduli,
and dynamic stiffness of the arterial wall.
Results: The diameter and wall thickness of CCA, ECA and ICA were
found to decrease and dynamic stiffness to increase from proximal CCA to
distal ECA and ICA. The circumferential stress from end-diastole to peak-
systole varied nonlinearly from 257 to 63  23 kPa (CCA), from 22  7
to 57  19 kPa (ECA) and from 28  8 to 67  23 kPa (ICA). Tangent
elastic moduli also varied nonlinearly as follows: from 0.40 0.25 to 1.50
2.05 MPa (CCA), from 0.490.34 to 1.14  0.52 MPa (ECA) and from
0.68 0.31 to 1.51 0.69 MPa (ICA). The dynamic stiffness of CCA and
ECA increased more than 3-fold and the dynamic stiffness of ICA increased
more than 2.5-fold at peak-systole compared to end-diastole.
Conclusions: The in vivo mechanical behavior of CCA, ECA and
ICA was qualitatively similar, but quantitatively different. All three
arteries exhibited nonlinear variations of circumferential stress and tan-
gent elastic moduli within the normal pressure range. The variability in
the properties of CCA, ECA and ICA indicates a need for development of
carotid models that match the in vivo properties of the carotid segments.
The observed nonlinear behavior points to the need for future vascular
mechanical studies to evaluate the mechanical factors of the arterial wall
over the entire cardiac cycle.
Connecting the True Lumen: A Multicenter Experience Evaluating
Chronic Total Occlusion Crossing With the Wildcat Catheter (the
Connect Study)
John P. Pigott, MD, M. Laiq Raja, MD, Tom Davis, MD, Jobst Vascular
Institute, Jobst Vascular Institute, Toledo, Ohio
Objectives: Percutaneous techniques for crossing femoropopliteal
chronic total occlusions (CTOs) offer an alternative to bypass surgery in
patients deemed to be at increased risk due to advanced age or comorbidi-
ties. Current research demonstrates increasing success rates in catheters
designed to reconstitute peripherally occluded arteries following failed
guidewire passage. The Wildcat CTO catheter is a novel device with a
rotating distal tip and deployable wedges fashioned for channeling a passage
through arterial occlusions. (Fig). This combination is designed to improve
overall operator device control and create a more reliable true lumen passage
for therapeutic endpoints.
Methods: This study is a prospective, multicenter, non-randomized
trial. Enrolled patients demonstrated a CTO of the femoropopliteal arteries
and were not able to be successfully crossed with initial guidewire tech-
niques. The primary measured efficacy endpoint is guidewire placement into
the true distal lumen after Wildcat passage, as confirmed by angiography.
Secondary safety and efficacy endpoints were assessed within a 30-day
timeframe. Procedural site reporting was independently ratified by board-
certified angiographic reviewers.
b
wResults: A total of 88 patients were enrolled with an average CTO
ength of 174  96mm, 89% (n  78) of which were de novo lesions.
pproximately 55% (n 48) of all lesions were categorized as containing at
east moderate calcification. Greater than 85% (n  75) of vessels were
uperficial femoral arteries. The device was used in 84 of 88 patients.
uccessful CTO crossing was reported in 89.3% (75/84) of cases with 4.8%
4/84) major adverse events or clinically relevant complications (Table 1).
Conclusions: In this multicenter study, the Wildcat CTO Catheter
emonstrated an 89.3% (n75) crossing rate with little associatedmorbidity
n  0). Results surpassed the study design endpoints.
Answers to questions:
1. This new technology addresses a new method of crossing challeng-
ing femoropopliteal CTOs.
2. This can potentially improve interventional outcomes and proce-
dural patency
able. Primary safety and efficacy
verall efficacy 89.3% (75/84)
verall safety 95.2% (80/84)
ajor adverse event 0.0% (0/84)
1. Death
2. Unplanned major amputation
3. Emergent target vessel revascularization
linically significant perforation 4.8% (4/84)
linically significant embolization 0.0% (0/84)
rade C dissection 0.0% (0/84)
esults of Iliac Stenting for Iliac Artery Occlusions
achinder S. Hans, MD, Gul Sachwani, Michael D. Khoury, MD, Mayo
itsuya, Thomas King, Youssef Rizk, Luay Sayed,MD, Vascular Surgery, St
ohn Macomb, Warren, Mich
Objective: The aim of this study was to evaluate the results of iliac
tenting for iliac artery occlusions.
Methods: A retrospective review of 105 consecutive patients with iliac
rtery occlusions treated by percutaneous iliac stenting from 1998 to 2010
as completed from two teaching hospitals. Demographic and risk factor
ata was compiled. Primary and secondary patency was determined by
aplan-Meier analysis.
Results: One hundred and five patients underwent attempted angio-
lasty/stenting of an iliac artery occlusion. 96 iliac artery occlusions were
uccessfully treated (technical success 91%). Indications for the procedure
ere life style-altering claudication in 68 patients (70%), ischemic rest pain
6 (17%) and ischemic ulcer/toe gangrene 12 (13%). Iliac stenting was
erformed for 50 common iliac artery occlusions (TASC B), 36 external iliac
rtery occlusions (TASC C) and 10 combined common and external iliac
rtery occlusions (TASCD). Four patients underwent simultaneous femoral
rtery endarterectomy. Contralateral iliac stenosis was present in 52 patients
nd twenty-seven had infrainguinal arterial occlusive disease. Unilateral
emoral access 50, bilateral femoral 35, brachial artery 2 and combined
Fig.rachial and femoral access was used in 9 patients. Thrombolysis with TPA
as performed prior to iliac stenting (n3). Technical aids for crossing the
